Credit Agricole S A Gilead Sciences, Inc. Transaction History

Credit Agricole S A

$18.2 Billion
Q2 2024

A detailed history of Credit Agricole S A transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Credit Agricole S A holds 335,514 shares of GILD stock, worth $28.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

335,514

Previous 97,534 244.0%

Holding current value

$28.4 Million

Previous $7.14 Million 222.21%

% of portfolio

0.13%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $15 Million - $17.3 Million	237,980 Added 244.0%	335,514 $23 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $3.99 Million - $4.87 Million	55,793 Added 133.66%	97,534 $7.14 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $1.19 Million - $1.35 Million	16,264 Added 63.84%	41,741 $3.38 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $1.62 Million - $1.76 Million	21,844 Added 601.27%	25,477 $1.91 Million
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $5,700 - $6,502	-75 Reduced 2.02%	3,633 $279,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $13,142 - $14,973	170 Added 4.8%	3,708 $307,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $641,771 - $921,362	-10,298 Reduced 74.43%	3,538 $303,000
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $1.22 Million - $1.39 Million	-20,490 Reduced 59.69%	13,836 $854,000
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $192,207 - $216,483	-3,330 Reduced 8.84%	34,326 $2.12 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $41,992 - $52,620	725 Added 1.96%	37,656 $2.24 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $129,500 - $146,985	-1,996 Reduced 5.13%	36,931 $2.68 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $969,659 - $1.05 Million	-14,325 Reduced 26.9%	38,927 $2.72 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $66,262 - $72,401	1,044 Added 2.0%	53,252 $3.67 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $1.35 Million - $1.54 Million	-22,444 Reduced 30.06%	52,208 $3.38 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $2.63 Million - $3 Million	46,450 Added 164.7%	74,652 $4.35 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1.25 Million - $1.57 Million	-20,112 Reduced 41.63%	28,202 $1.78 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $401,848 - $466,620	5,555 Added 12.99%	48,314 $3.72 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $393,441 - $503,942	6,282 Added 17.22%	42,759 $3.2 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $468,250 - $515,060	7,599 Added 26.31%	36,477 $2.37 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $364,433 - $402,270	5,830 Added 25.3%	28,878 $1.83 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $250,573 - $280,989	4,050 Added 21.32%	23,048 $1.56 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $3.47 Million - $3.89 Million	-55,524 Reduced 74.51%	18,998 $1.24 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $154,377 - $201,450	2,550 Added 3.54%	74,522 $4.66 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $3.46 Million - $3.83 Million	48,546 Added 207.23%	71,972 $5.56 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $32,439 - $37,840	500 Added 2.18%	23,426 $1.66 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $166,803 - $203,352	2,290 Added 11.1%	22,926 $1.73 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $155 Million - $182 Million	-2,184,455 Reduced 99.06%	20,636 $1.48 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $5.49 Million - $6.51 Million	-76,140 Reduced 3.34%	2,205,091 $179 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,281,231	2,281,231 $161 Million

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.

Account

Credit Agricole S A Gilead Sciences, Inc. Transaction History